ReleaseWire Connect

Presently, North America dominates the industrial wireless sensor network market. However, China is expected to register the highest growth in Asia-Pacific by 2023. Moreover, the UK is anticipated led the overall market in the European region in 2023. Presently, the U.S. dominates the North American market.

According to a recent report published by Allied Market Research, titled, Business Analytics Software Market by Deployment Model, End User, and Application: Global Opportunity Analysis and Industry Forecast, 2017-2023, the global business analytics software market was valued at $45,043 million in 2016, and is projected to reach at $86,451 million by 2023, growing at a CAGR of 9.7% from 2017 to 2023. In 2016, the cloud segment accounted for the highest revenue share in the business analytics software market.

According to a new report published by Allied Market Research, titled, Vaginal Slings Market by Type, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023, the global vaginal slings market was valued at $628 million in 2016, and is projected to reach $1,626 million by 2023, growing at a CAGR of 14.5% from 2017 to 2023. The conventional vaginal slings accounted for three-fifths share of the global market in 2016.

The fuel refill application segment witnessed high demand in 2016, as fuel cards help to determine the gallons or liters of fuel filled along with the details on mileage of vehicles. In addition, increase in usage of cashless payment methods, growth associated with prepaid cards, and rise in number of fleet owners and small and medium enterprises are expected to fuel the fuel cards market growth in the near future. Moreover, the vehicle service segment witnessed increased adoption of fuel cards across various regions, owing to increase in number of fleets globally that use cards to pay for vehicle maintenance and expenses at the discretion of the fleet owner.

System-on-chip (SoC) applications are majorly adopted in the Asia-Pacific region; thus, this region contributes to maximum revenue in the global market, followed by North America, Europe, and LAMEA.

According to a new report published by Allied Market Research, titled, Anesthesia and Respiratory Devices Market by Product and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global anesthesia and respiratory devices market accounted for $23,446 million in 2016, and is estimated to reach $38,298 million by 2023, registering a CAGR of 7.2% from 2017 to 2023. North America was the highest contributor in the anesthesia and respiratory devices market in 2016; however, Asia-Pacific is expected to witness the highest growth rate during the forecast period.

According to a new report published by Allied Market Research, titled, Wax Market by Type, and Application: Global Opportunity Analysis and Industry Forecast, 2017-2023, the global wax market was valued at $9,322 million in 2016, and is projected to reach at $11,780 million by 2023, registering a CAGR of 3.4% from 2017 to 2023.

According to a new report published by Allied Market Research, titled, Hand Sanitizer Market by Product, Distribution Channel, and End Use: Global Opportunity Analysis and Industry Forecast, 2017-2023," the hand sanitizer market size was valued at $919 million in 2016, and is projected to reach $1,755 million by 2023, growing at a CAGR of 9.9% from 2017 to 2023. North America was the largest contributor in 2016, accounting for around 35% of the market share.

According to a new report by Allied Market Research, titled, Smart Glove Market by Usage and by Industrial Vertical: Global Opportunities Analysis and Industry Forecast, 2017-2023, the global smart glove market was valued at $ 1,740 million in 2016, and is projected to reach at $3,373 million by 2023, growing at a CAGR of 9.5% from 2017 to 2023.

Gene therapies are promising therapies applicable to a broad range of diseases; their aim is to radically treat the causes of the diseases instead of only relieving the symptoms. They may be effective on a wide range of previously untreated diseases, such as hematological, ocular, neurodegenerative diseases, and several cancers. For example, adeno-associated AAV2 vectors carrying the therapeutic gene (RPE65) intra-retinal injection resulted in improved vision for people with Lebers Congenital Amaurosis. Gene therapies can be applied either in combination with cell products and through an ex vivo treatment mode (e.g. Strimvelis), or directly administered in vitro (e.g. Glybera). Several vectors present clinically relevant options, including adenovirus (AV), adeno-associated virus (AAV), and lentivirus.